欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号NL/H/4183/002
药品名称Bortezomib 3,5 mg
活性成分
    • Bortezomib 3.5 mg
剂型Powder for solution for infusion
上市许可持有人Waverley Pharma Europe Limited Alexandra House, Office 234, The Sweepstakes, Ballsbridge, Dublin 4, D04 C7H2, Ireland
参考成员国 - 产品名称Netherlands (NL)
Bortezomib Waverley 3,5 mg poeder voor oplossing voor injectie
互认成员国 - 产品名称
    • Denmark (DK)
    • Luxembourg (LU)
    • France (FR)
    • Spain (ES)
    • Italy (IT)
许可日期2020/02/11
最近更新日期2024/12/03
药物ATC编码
    • L01XX32 bortezomib
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Additional Strength/Form
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase